Arellano-Arteaga Kevin J, Bayro Jablonski Nikolai Emmanuel, Miramontes Luna Elvira, Bedolla-Barajas Martín, Coronel Castañeda Luz Gardenia
Department of Clinical Medicine/Internal Medicine, University Center for Health Science, University of Guadalajara, Guadalajara, MEX.
Department of Internal Medicine, Nuevo Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalajara, MEX.
Cureus. 2023 Jul 4;15(7):e41365. doi: 10.7759/cureus.41365. eCollection 2023 Jul.
Biventricular takotsubo cardiomyopathy (BiTCM) is a rare entity, seldom reported. We describe a case of a female presenting with multisystemic inflammatory syndrome associated with the administration of a vaccine against coronavirus disease 2019 (COVID-19). In this particular case, the patient experienced the onset of symptoms shortly after receiving a COVID-19 vaccine. Early recognition of biventricular takotsubo cardiomyopathy and timely initiation of appropriate treatment are crucial. Prompt management includes stabilizing the patient's hemodynamic status, alleviating symptoms, and addressing any underlying causes, such as inflammation or immune-related responses. Close clinical surveillance is necessary to monitor the patient's cardiac function, assess response to treatment, and prevent potential complications.
双心室Takotsubo心肌病（BiTCM）是一种罕见的疾病，鲜有报道。我们描述了一例女性患者，其出现了与接种2019冠状病毒病（COVID-19）疫苗相关的多系统炎症综合征。在这个特殊病例中，患者在接种COVID-19疫苗后不久就出现了症状。早期识别双心室Takotsubo心肌病并及时开始适当治疗至关重要。迅速的处理措施包括稳定患者的血流动力学状态、缓解症状以及处理任何潜在病因，如炎症或免疫相关反应。密切的临床监测对于监测患者的心脏功能、评估治疗反应以及预防潜在并发症是必要的。
